203 related articles for article (PubMed ID: 19915609)
1. Activity and cellular localization of an oncogenic glioblastoma multiforme-associated EGF receptor mutant possessing a duplicated kinase domain.
Ozer BH; Wiepz GJ; Bertics PJ
Oncogene; 2010 Feb; 29(6):855-64. PubMed ID: 19915609
[TBL] [Abstract][Full Text] [Related]
2. The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling.
Huang HS; Nagane M; Klingbeil CK; Lin H; Nishikawa R; Ji XD; Huang CM; Gill GN; Wiley HS; Cavenee WK
J Biol Chem; 1997 Jan; 272(5):2927-35. PubMed ID: 9006938
[TBL] [Abstract][Full Text] [Related]
3. The protein tyrosine phosphatase TCPTP suppresses the tumorigenicity of glioblastoma cells expressing a mutant epidermal growth factor receptor.
Klingler-Hoffmann M; Fodero-Tavoletti MT; Mishima K; Narita Y; Cavenee WK; Furnari FB; Huang HJ; Tiganis T
J Biol Chem; 2001 Dec; 276(49):46313-8. PubMed ID: 11514572
[TBL] [Abstract][Full Text] [Related]
4. Her4 and Her2/neu tyrosine kinase domains dimerize and activate in a reconstituted in vitro system.
Monsey J; Shen W; Schlesinger P; Bose R
J Biol Chem; 2010 Mar; 285(10):7035-44. PubMed ID: 20022944
[TBL] [Abstract][Full Text] [Related]
5. ERK-dependent threonine phosphorylation of EGF receptor modulates receptor downregulation and signaling.
Li X; Huang Y; Jiang J; Frank SJ
Cell Signal; 2008 Nov; 20(11):2145-55. PubMed ID: 18762250
[TBL] [Abstract][Full Text] [Related]
6. Glycosylation-induced conformational modification positively regulates receptor-receptor association: a study with an aberrant epidermal growth factor receptor (EGFRvIII/DeltaEGFR) expressed in cancer cells.
Fernandes H; Cohen S; Bishayee S
J Biol Chem; 2001 Feb; 276(7):5375-83. PubMed ID: 11087732
[TBL] [Abstract][Full Text] [Related]
7. Ligand regulates epidermal growth factor receptor kinase specificity: activation increases preference for GAB1 and SHC versus autophosphorylation sites.
Fan YX; Wong L; Deb TB; Johnson GR
J Biol Chem; 2004 Sep; 279(37):38143-50. PubMed ID: 15231819
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor as a therapeutic target in glioblastoma.
Kalman B; Szep E; Garzuly F; Post DE
Neuromolecular Med; 2013 Jun; 15(2):420-34. PubMed ID: 23575987
[TBL] [Abstract][Full Text] [Related]
9. Distinct domains in the SHP-2 phosphatase differentially regulate epidermal growth factor receptor/NF-kappaB activation through Gab1 in glioblastoma cells.
Kapoor GS; Zhan Y; Johnson GR; O'Rourke DM
Mol Cell Biol; 2004 Jan; 24(2):823-36. PubMed ID: 14701753
[TBL] [Abstract][Full Text] [Related]
10. Src-dependent phosphorylation of the epidermal growth factor receptor on tyrosine 845 is required for zinc-induced Ras activation.
Wu W; Graves LM; Gill GN; Parsons SJ; Samet JM
J Biol Chem; 2002 Jul; 277(27):24252-7. PubMed ID: 11983694
[TBL] [Abstract][Full Text] [Related]
11. Sustained mitogen-activated protein kinase activation is induced by transforming erbB receptor complexes.
Wu CJ; Qian X; O'Rourke DM
DNA Cell Biol; 1999 Oct; 18(10):731-41. PubMed ID: 10541432
[TBL] [Abstract][Full Text] [Related]
12. Evidence that autophosphorylation of solubilized receptors for epidermal growth factor is mediated by intermolecular cross-phosphorylation.
Honegger AM; Kris RM; Ullrich A; Schlessinger J
Proc Natl Acad Sci U S A; 1989 Feb; 86(3):925-9. PubMed ID: 2915986
[TBL] [Abstract][Full Text] [Related]
13. Mechanism for activation of mutated epidermal growth factor receptors in lung cancer.
Red Brewer M; Yun CH; Lai D; Lemmon MA; Eck MJ; Pao W
Proc Natl Acad Sci U S A; 2013 Sep; 110(38):E3595-604. PubMed ID: 24019492
[TBL] [Abstract][Full Text] [Related]
14. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.
Li J; Ma C; Huang Y; Luo J; Huang C
Oncogene; 2003 Jan; 22(2):211-9. PubMed ID: 12527890
[TBL] [Abstract][Full Text] [Related]
15. Structure-function analysis of oncogenic EGFR Kinase Domain Duplication reveals insights into activation and a potential approach for therapeutic targeting.
Du Z; Brown BP; Kim S; Ferguson D; Pavlick DC; Jayakumaran G; Benayed R; Gallant JN; Zhang YK; Yan Y; Red-Brewer M; Ali SM; Schrock AB; Zehir A; Ladanyi M; Smith AW; Meiler J; Lovly CM
Nat Commun; 2021 Mar; 12(1):1382. PubMed ID: 33654076
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor-receptor mutant lacking the autophosphorylation sites induces phosphorylation of Shc protein and Shc-Grb2/ASH association and retains mitogenic activity.
Gotoh N; Tojo A; Muroya K; Hashimoto Y; Hattori S; Nakamura S; Takenawa T; Yazaki Y; Shibuya M
Proc Natl Acad Sci U S A; 1994 Jan; 91(1):167-71. PubMed ID: 7506413
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
Huang Y; Kim SO; Jiang J; Frank SJ
J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595
[TBL] [Abstract][Full Text] [Related]
18. EGF receptor exposed to oxidative stress acquires abnormal phosphorylation and aberrant activated conformation that impairs canonical dimerization.
Filosto S; Khan EM; Tognon E; Becker C; Ashfaq M; Ravid T; Goldkorn T
PLoS One; 2011; 6(8):e23240. PubMed ID: 21853092
[TBL] [Abstract][Full Text] [Related]
19. Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiforme.
Learn CA; Hartzell TL; Wikstrand CJ; Archer GE; Rich JN; Friedman AH; Friedman HS; Bigner DD; Sampson JH
Clin Cancer Res; 2004 May; 10(9):3216-24. PubMed ID: 15131063
[TBL] [Abstract][Full Text] [Related]
20. An EGFR wild type-EGFRvIII-HB-EGF feed-forward loop regulates the activation of EGFRvIII.
Li L; Chakraborty S; Yang CR; Hatanpaa KJ; Cipher DJ; Puliyappadamba VT; Rehman A; Jiwani AJ; Mickey B; Madden C; Raisanen J; Burma S; Saha D; Wang Z; Pingle SC; Kesari S; Boothman DA; Habib AA
Oncogene; 2014 Aug; 33(33):4253-64. PubMed ID: 24077285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
